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Abstract
Vaccinia virus (VACV), a member of the chordopox subfamily of the Poxviridae, abortively infects insect cells. We have
investigated VACV infection of Drosophila S2 cells, which are useful for protein expression and genome-wide RNAi
screening. Biochemical and electron microscopic analyses indicated that VACV entry into Drosophila S2 cells depended on
the VACV multiprotein entry-fusion complex but appeared to occur exclusively by a low pH-dependent endocytic
mechanism, in contrast to both neutral and low pH entry pathways used in mammalian cells. Deep RNA sequencing
revealed that the entire VACV early transcriptome, comprising 118 open reading frames, was robustly expressed but neither
intermediate nor late mRNAs were made. Nor was viral late protein synthesis or inhibition of host protein synthesis detected
by pulse-labeling with radioactive amino acids. Some reduction in viral early proteins was noted by Western blotting.
Nevertheless, synthesis of the multitude of early proteins needed for intermediate gene expression was demonstrated by
transfection of a plasmid containing a reporter gene regulated by an intermediate promoter. In addition, expression of a
reporter gene with a late promoter was achieved by cotransfection of intermediate genes encoding the late transcription
factors. The requirement for transfection of DNA templates for intermediate and late gene expression indicated a defect in
viral genome replication in VACV-infected S2 cells, which was confirmed by direct analysis. Furthermore, VACV-infected S2
cells did not support the replication of a transfected plasmid, which occurs in mammalian cells and is dependent on all
known viral replication proteins, indicating a primary restriction of DNA synthesis.
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Introduction
The Poxviridae, a family of large enveloped double-stranded DNA
viruses that replicate exclusively in the cytoplasm, are divided into
chordopox and entomopox subfamilies, which infect vertebrate and
invertebrates respectively [1]. Approximately 100 genes are
conserved in all chordopoxviruses and about half of these can be
identified in entomopoxviruses [2]. Although host restrictions
prevent the complete replication of chordopoxviruses in insect cells
and entomopoxviruses in mammalian cells, viral protein synthesis
has been detected under non-permissive conditions [3]. Amsacta
moorei, the prototypic entomopoxvirus, expresses only early genes in
vertebrate cells [4]. Someviral early and late gene expression as well
as DNA replication occur in gypsy moth cells infected with vaccinia
virus (VACV), the prototypic chordopoxvirus that was used for
smallpox eradication, but assembly of virus particles fails to occur
[5]. In VACV-infected Drosophila S2 cells, only expression of the
beta-galactosidase reportergeneregulatedbyanearlypromoterwas
detected [6], suggesting variations in the extent to which insect cells
can support chordopoxvirus replication.
The nearly 200-kbp double-stranded genome of VACV codes
for approximately 200 proteins with roles in entry, RNA and DNA
synthesis, morphogenesis, and host interactions [1]. The VACV
replication cycle begins with the attachment of virions to
glycosaminoglycans or laminin on the cell surface [7,8,9,10] and
entry proceeds concurrently by fusion of the viral membrane with
the plasma membrane and with low-pH vesicle membranes
following endocytosis, with the extent that each pathway is used
depending on the virus strain and cell type [11,12,13]. The entry-
fusion complex (EFC), comprised of more than 10 viral membrane
proteins, is required for infection [14,15,16,17,18,19,20,21,22,
23,24,25]. Entry of the core, containing a complete transcription
system, into the cytoplasm results in the production of more than
100 early mRNA species [26]. The early mRNAs encode proteins
required for replication of the genome and transcription of
intermediate stage mRNAs. Following DNA replication, interme-
diate mRNAs encoding late transcription factors and late mRNAs
encoding virion components are synthesized and translated within
cytoplasmic factories, where virions are then assembled [27]. The
infectious mature virion (MV) consists of a nucleoprotein core
surrounded by a single membrane bilayer containing about 20
viral proteins [28]. Most of the MVs remain in the cell until lysis;
however, a subset are wrapped with modified Golgi or endosomal
membranes, transported to the periphery and released from the
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[29].
Poxviruses are generally considered to be more self-sufficient
than many other viruses owing to their large genomes and
cytoplasmic site of replication. In this context, we were motivated
to further investigate the inability of VACV to complete its
replication cycle in insect cells. Our interest was further stimulated
by the availability of powerful tools for genetic analysis,
particularly the robust RNAi system for Drosophila [30]. An RNAi
kinome (,440 genes encoding protein kinases, phosphatases and
regulatory factors) screen of VACV infection of Drosophila cells
identified AMP-activated kinase as an essential entry factor that is
conserved in mammals [6]. In order to more fully exploit the
Drosophila system for genome-wide screens, it is important to
further characterize the replication block for VACV. Here we
showed that VACV entry into a Drosophila S2 cell depended on the
EFC but appeared to occur exclusively by a low pH-dependent
endocytic mechanism, in contrast to the dual entry pathways used
in mammalian cells. Deep RNA sequencing revealed that the
entire VACV early transcriptome was expressed. Nevertheless,
replication of the viral genome and late stage mRNA and proteins
were not detected. Replication of a transfected plasmid also failed
to occur, indicating a block beyond uncoating of the virus core. In
addition, the synthesis of post-replicative stage proteins could be
overcome by transfecting plasmids with intermediate and late
promoters, consistent with a primary block in DNA replication.
Results
Entry of VACV into S2 cells requires components of the
EFC
We used a recombinant VACV strain WR containing the firefly
Luc gene regulated by the synthetic early/late promoter to
determine entry unless otherwise stated. Drosophila S2 and African
green monkey BS-C-1 cells were infected with various amounts of
virus and Luc activity was measured after 1 h (Fig. 1A). Activity
was proportional to the multiplicity of infection but was about 2-
logs higher in BS-C-1 than S2 cells. Since BS-C-1 and S2 cells are
grown and maintained at 37uC and 25uC, respectively, we tested
the effects of temperature. Whereas Luc activity increased from 25
to 31 to 37uC in BS-C-1 cells, the S2 cells had maximal Luc
activity at 31uC (Fig. 1B). In subsequent experiments, both BS-C-1
and S2 cells were incubated at the compromise temperature of
31uC following virus attachment.
To determine whether the relatively low Luc expression in S2
cells was due to slower kinetics, activity was measured over a 48 h
period in the presence or absence of AraC, an inhibitor of DNA
replication. Under the former condition, only early gene
expression could occur. In S2 cells, expression reached a plateau
at 6 h in the presence or absence of inhibitor (Fig. 1C), suggesting
that only early gene expression occurred under both conditions. In
contrast, Luc expression continued for more than 24 h in BS-C-1
cells in the absence of AraC but plateaued earlier in the presence
of the inhibitor (Fig. 1C), consistent with early and late gene
expression under the former conditions. Taken together, the data
indicated that either entry or subsequent gene expression of
VACV was lower in S2 cells than in mammalian cells and
suggested that only early gene expression occurred in S2 cells.
To investigate whether entry of VACV into S2 cells occurs by
mechanisms used in mammalian cells, we determined the effects of
the neutralizing MAb 7D11 targeted to the L1 entry protein. As
shown in Fig. 2A, VACV WR entry was inhibited by MAb 7D11
in both BS-C-1 and S2 cells. To more directly assess the role of the
EFC, a recombinant VACV with the gene encoding the A28 EFC
protein regulated by the Escherichia coli lac repressor and expressing
Luc was constructed. Infectious and non-infectious virions were
prepared by infecting BS-C-1 cells in the presence and absence of
the inducer IPTG as previously described [14]. The virions made
in the presence of IPTG contained A28 whereas those made in the
absence of IPTG lacked A28. Entry of virions lacking A28 was
severely inhibited in both cell types (Fig. 2B). We concluded that
components of the VACV entry fusion complex are required for
entry in S2 cells.
Entry of VACV into S2 cells occurs by low pH-dependent
endocytosis
Entry of VACV strain WR into mammalian cells occurs by two
routes simultaneously: direct fusion with the plasma membrane
and low pH-dependent endocytosis. The latter pathway was
established by showing that brief low pH treatment accelerated
entry through the plasma membrane by mimicking the pH of
endosomes and by preventing endosomal acidification with
inhibitors [11]. In the present study, we found that VACV entry
into S2 cells, measured by Luc activity, was enhanced less than 2-
Figure 1. Entry of VACV in Drosophila S2 cells. A) BS-C-1 and S2 cells were incubated with purified WRvFire virions at 4uC at neutral pH for 1 h at
the indicated MOI to allow attachment, washed, and then incubated for 1 h at 37uC for BS-C-1 cells and 25uC for S2 cells. Cells were lysed and Luc
activity measured and plotted as relative light units (RLU). B) Cells were infected as in panel A with a MOI of 2 PFU per cell and after virus attachment
the plates were incubated at the indicated temperatures for 2 h and then assayed for Luc. C) Cells were infected with an MOI of 1 PFU per cell as in
panel A. After attachment, plates were incubated at 31uC and Luc assays were made over a 48 h period. Note that the solid and dashed lines
representing Luc activity from S2 cells in the presence and absence of AraC are practically superimposed. Standard error bars were plotted in all three
panels but are too close to discern in some places.
doi:10.1371/journal.pone.0017248.g001
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to 8-fold enhancement of entry into HeLa S3 cells (Fig. 3A).
Bafilomycin A1 inhibited VACV entry into BS-C-1 cells by about
50% and exposure of bound virions to pH 5 buffer in the presence
of inhibitor allowed entry to recover to 70% of control (Fig. 3C).
Remarkably, bafilomycin A1 inhibited entry of VACV in S2 cells
by 99% and was still 95% below the control after exposure to
pH 5 buffer (Fig. 3C), suggesting that entry occurred predomi-
nantly or exclusively through a low pH endosomal route.
We previously showed strain differences in the mode of entry of
VACV into mammalian cells. Entry as measured by Luc activity
was higher for IHD-J than WR at neutral pH; however, entry of
IHD-J was neither accelerated by brief low pH treatment nor
inhibited by bafilomycin A1 [12]. In S2 cells, however, the
situation was reversed: WR entry was higher than IHD-J (Fig. 3B).
The defect was not due to poor binding of the IHD-J strain to S2
cells as determined by flow cytometry using recombinant viruses
with GFP fused to a core protein (data not shown). The results
with IHD-J were consistent with an inability of S2 cells to support
neutral pH entry of VACV.
Viruses enter cells by a variety of endocytic mechanisms [31].
Studies of VACV entry in mammalian cells indicated a
requirement for cell signaling and actin dynamics, consistent with
macropinocytosis [32] or dynamin 2-dependent fluid phase uptake
pathways [33]. VACV infection of S2 cells is reduced to varying
degrees by latrunculin A, wortmannin, rottlerin, 5-(N-ethyl-N-
isopropyl)amirolide, known inhibitors of actin dynamics or
macropinocytosis [6]. We found that genistein, a broad-spectrum
tyrosine kinase inhibitor (Fig. 3D), dynasore, a dynamin GTPase
inhibitor (Fig. 3E) and blebbistatin (Fig. 3G), a myosin II inhibitor
reduced VACV WR entry into both BS-C-1 and S2 cells to similar
extents. Cytochalasin D (Fig. 3F), an inhibitor of actin polymer-
ization, reduced entry into BS-C-1 cells by greater than 95%, but
inhibited entry into S2 cells by ,50%. Except for the latter
quantitative difference, the entry requirements for VACV WR in
S2 and mammalian cells appeared to be similar, with the major
difference being the apparent inability to enter S2 cells by an
alternative neutral pH route.
Visualization of VACV infection of S2 cells
Since the reporter gene assay measures a post-entry event,
transmission electron microscopy was employed to visualize
VACV infection of S2 cells. After 1 h of incubation at 31uC,
numerous virions were at the cell surface particularly near
protrusions but none were seen fusing with the plasma membrane
(Fig. 4A), in contrast to the situation with BS-C-1 cells [11]. The
S2 cells contained large numbers of virions in vesicles whereas
cores, with a distinctive oval shape and brush-like surface, were
detected in the nearby cytoplasm (Fig. 4B–D). The number of
virions in endosomes increased from 0.5 to 1 h whereas the
number of cores in the cytoplasm continued to increase for the 2 h
period analyzed (Fig. 5A,B). At the latter time, the number of cores
was about one-fourth the number of endosomal virions, indicating
relatively efficient entry into the cytoplasm.
Transcriptome analysis of VACV infected S2 cells
The efficient entry of cores into the cytoplasm of S2 cells
contrasted with the low Luc activity, suggesting that transcription
or translation was limiting. Recently, we showed that the entire
VACV transcriptome could be analyzed by deep sequencing of
total polyadenylated RNA from HeLa cells [26]. The same
technique was applied to infected S2 cells. Total polyadenylated
RNA was isolated at 0, 2, 6 and 12 h post infection and cDNAs
were prepared and sequenced with an Applied Biosystems SOLiD
analyzer. Approximately 7 million to 20 million mappable reads
were obtained for each time point and were divided into those that
contained cellular or viral sequences. Viral sequence reads
represented about 5% of the total at 6 h (Fig. 6), which is in the
range (4 to 11%) occurring in HeLa cells prior to DNA replication
[26].
Individual reads were aligned to the VACV genome to
construct single-base-resolution maps of the VACV transcriptome
in S2 cells. The reads per nucleotide were plotted along the
annotated genome, which was color coded for open reading
frames (ORFs) expressed before (green) and after (red) DNA
replication (Fig. 7A). Reads above the line represent cDNAs
prepared from mRNAs transcribed from the upper DNA strand in
the rightward direction of the genome, and reads below the line
represent mRNAs transcribed from the bottom DNA strand in the
leftward direction of the genome. Most of the VACV transcripts
detected at 2 h after infection were increased at 6 and 12 h, with
Figure 2. VACV entry into S2 cells is dependent on components
of the EFC. A) Purified WRvFire virions (WR) (MOI of 10 PFU per cell)
were incubated with or without the L1 MAb 7D11 (20 mg/ml) for 30 min
at room temperature and then added to BS-C-1 or S2 cells. After
attachment, the cells were incubated at 31uC for 1 h and assayed for
Luc. B) BS-C-1 and S2 cells were incubated with purified WRvFire virions
(WR) or A28ivFire virions (MOI of 10 PFU per cell) containing (+)o r
lacking (-) the A28 protein. After attachment, the cells were incubated
for 1 h and assayed for Luc. Standard error bars were plotted in both
panels but are too close to discern in some places.
doi:10.1371/journal.pone.0017248.g002
Vaccinia Virus Infection of Drosophila Cells
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genome and the minus strand at the left end of the genome,
corresponding to the positions of the majority of early genes. This
pattern was very similar to the VACV early transcriptome maps at
0.5 to 2 h in human cells and in the presence of DNA and protein
synthesis inhibitors [26]. At 4 h in human cells, however, the
transcription pattern changes drastically correlating with the onset
of DNA replication followed by late mRNA synthesis [26],
whereas this late pattern was not observed even 12 h after
infection of S2 cells.
An enlarged view of the HindIII D segment of the VACV
genome, indicating the ORFs expressed at early and late times in
mammalian cells, is shown in Fig. 7B. The transcripts from
VACV-infected S2 cells aligned with the early ORFs but not the
late ones (Fig. 7B), precisely as had been found by deep RNA
sequencing of RNA from infected HeLa cells [26] and determined
Figure 3. Effects of pH and chemical inhibitors on VACV entry. A) HeLa and S2 cells were incubated with purified WRvFire virions at 4uC for
1 h at a MOI of 2 PFU per cell. After attachment, cells were washed and incubated with pH 5 or pH 7.4 buffer for 3 min at 37uC. Cells were then
washed and incubated at 31uC at neutral pH for 2 h and Luc assayed. B) BS-C-1 and S2 cells were infected with WRvFire or IHD-JvFire virions at
neutral pH and Luc assayed as in panel A. C) BS-C-1 and S2 cells were infected as above except cells were pre-treated with bafilomycin A1 for 1 h at
31uC and then pre-chilled to 4uC prior to virion attachment, followed by wash and pH treatment. Inhibitor was maintained in the media throughout
the infection. BS-C-1 and S2 cells were pretreated with: D) genistein; E) dynasore; F) cytochalasin; G) blebbistatin followed by wash and incubation at
31uC for 2 h. Standard error bars were plotted in all panels but are too close to discern in some places.
doi:10.1371/journal.pone.0017248.g003
Figure 4. Transmission electron microscopy of VACV infected S2 cells. Purified VACV virions were spinoculated onto cells for 1 h at 4uCa ta
MOI of 150 PFU per cell. The cells were then incubated at 31uC. A) Low magnification of virions associated with cells and in endosomes at 1 h after
infection. B–D) Higher magnifications showing virions in vesicles and cores in the cytoplasm at 1 h after infection. V, virions; Endo, endosome. A size
marker is present at the lower right corner of each panel.
doi:10.1371/journal.pone.0017248.g004
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some early transcripts overlapped the start of adjacent late
transcripts. There was also a general correspondence between
the relative numbers of reads for individual ORFs, e.g. the reads
for D7 were lowest in both S2 and HeLa cells. The read counts of
the VACV ORFs at each time point are listed in Table S1 and
illustrate the early expression pattern for the entire genome.
Protein synthesis in VACV-infected S2 cells
BS-C-1 and S2 cells were infected with recombinant VACVs
containing the Luc gene regulated by a synthetic early/late
promoter or the p11 late promoter and incubated at 4uC, 25uC,
31uC and 37uC for 16 h. In BS-C-1 cells, the highest level of
expression from the early/late and late promoters were at 37uC and
31uC, respectively (Fig. 8A). In S2 cells (Fig. 8B), Luc expression
under the early/late promoter was higher at 31uC and 25uC
compared to 37uC and the activity was barely above background
with the late promoter (note the log scale). These results suggested
that VACV is unable to mediate late gene expression in S2 cells.
Pulse-labeling experiments were carried out to confirm the
above interpretation and to assess the effects of VACV on
expression of cellular proteins. In mammalian cells, host protein
synthesis is drastically reduced at 6 h after infection, allowing
detection of abundant late protein bands as shown in Fig. 8C. In
contrast, VACV had no discernable effect on synthesis of
Drosophila proteins and intense viral protein bands were not
detected at the multiplicity of 20 PFU per cell used (Fig. 8D).
The defect in viral late protein synthesis was confirmed by
Western blotting using antibody to A3 core protein (not shown)
and by the absence of immature virus particles in thin sections of
cells viewed by transmission electron microscopy (not shown). The
only sign of de novo gene expression was the clearing of areas of
the cytoplasm suggesting pre-factories.
Expression of intermediate and late proteins from a
transfected DNA template
Based on the results so far, the abortive VACV replication in S2
cells could be due to a primary block at the stage of viral DNA
replication or intermediate and late transcription. Except for the
ancillary use of cellular DNA ligase 1 [35], no mammalian host
factors have yet been found for VACV DNA replication, whereas
in vitro studies have demonstrated specific host factor require-
ments for both intermediate and late transcription [36,37]. The
DNA replication requirement for intermediate gene expression in
mammalian cells can be overcome by DNA transfection [38],
since the viral transcription factors needed are early gene products
[39]. We found that Luc expression occurred in VACV-infected
S2 cells when a plasmid containing the Luc gene under an
intermediate promoter was transfected (Fig. 9A), indicating the
synthesis of functional viral RNA polymerase and intermediate
transcription factors. Control experiments indicated no expression
when either the virus or expression plasmid was omitted (Fig. 9A).
The DNA replication requirement for late gene expression in
mammalian cells can be bypassed by transfecting plasmids
containing the three late transcription factor genes, which have
intermediate promoters, allowing detection of a reporter gene with
a late promoter in VACV-infected cells [40]. This was
accomplished in VACV-infected S2 cells by measuring expression
of Luc regulated by the late p11 promoter (Fig. 9B). Note that Luc
expression depended on VACV infection and co-transfection of
Figure 5. Quantification of virions in endosomes and cores in
cytoplasm. Data are from the same experiment used to obtain images
in Fig. 4. The numbers of virus particles were counted in single sections
of 90 different cells and the totals plotted: A) MVs in vesicles; B) cores in
cytoplasm.
doi:10.1371/journal.pone.0017248.g005
Figure 6. Relative amount of VACV mRNA in infected S2 cells.
Total polyadenylated RNA was extracted at various times after infection
and subjected to deep RNA sequencing. The sequences were divided
into those that mapped to the Drosophila and VACV genomes. The
percentage of the sequence hits to VACV genome relative to the total
mapped reads at progressive time after infection is shown.
doi:10.1371/journal.pone.0017248.g006
Vaccinia Virus Infection of Drosophila Cells
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indicated that both intermediate and late transcription and
translation could occur in S2 cells provided DNA templates are
transfected.
DNA replication
The results obtained so far suggested a block in VACV DNA
replication in S2 cells. This defect was verified by Southern
blotting: viral DNA was detected in BS-C-1 cells but not in S2 cells
(Fig. 10A). The absence of viral DNA synthesis could be due to
inaccessibility of the packaged viral genome, a failure of protein
uncoating or to a specific replication defect. To assess the latter, a
naked plasmid was transfected into BS-C-1 and S2 cells, since
circular DNAs without specific viral sequences replicate efficiently
in mammalian cells infected with VACV [41,42]. Moreover,
plasmid replication is dependent on expression of each of the viral
genes known to be required for genome replication [43]. Plasmid
replication, determined by real time PCR, increased over time in
VACV infected BS-C-1 cells but not in infected S2 cells or the
mock infected or transfected controls (Fig 10B). The inability of
the plasmid to replicate in infected S2 cells indicated a specific
block in DNA synthesis.
The defect in plasmid replication could be due to a host
restriction or insufficient amounts of viral replication proteins. We
Figure 7. VACV genome-wide transcriptome maps of S2 cells. A) The number of viral sequence reads per nucleotide was determined as
indicated in the legend to Fig. 6 and displayed over the entire VACV genome with early and post-transcriptional ORFs in green and red, respectively.
The counts above the line map to the upper (rightward) strand and counts below the line map to the lower (leftward) strand of the VACV genome.
The highest read counts are off-scale in the 2- to 12-h samples for display purposes. The counts were normalized by the total reads of the samples
and those duplicated because of their location within the inverted terminal repetition were divided by 2. The HindIII restriction map of the VACV
genome is shown at the bottom for reference purposes. B) The HindIII D region from the 6 h time point in panel A has been enlarged.
doi:10.1371/journal.pone.0017248.g007
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to viral replication proteins. The proteins I3 and A20 were
detected in BS-C-1 and in lesser amounts in S2 cells, though equal
amounts of protein lysates were loaded in the gels (Fig. 10C). D5
and E9 proteins from BS-C-1 cells were detected as faint bands but
were below the level of detection in S2 cells (Fig. 10C). Since the
mRNA levels for all four proteins were comparable in S2 and BS-
C-1 cells (Table S1, ref. 58), inefficient translation could contribute
to the defect in DNA replication. The relatively weak staining of
bands even in BS-C-1 cells, however, made it difficult to interpret
the significance of the lower staining in S2 cells.
Discussion
Drosophila S2 cells are used for high-level heterologous protein
synthesis employing DNA or baculovirus expression systems [44]
and for genome-wide siRNA knockdown [30]. Insect-specific
RNA viruses as well as several human RNA viruses, including
vesicular stomatitis virus, Sindbis virus, Rift Valley fever virus,
Dengue virus, and West Nile virus can productively infect S2 cells
[cited in [30]. During a recent RNAi kinome screen, Moser and
co-workers [6] found that VACV abortively infected S2 cells and
cited unpublished data that DNA replication was blocked. We
confirmed the abortive replication of VACV in Drosophila S2 cells
and analyzed each step in the replication cycle to better
understand the host restriction and provide the basis for
comprehensive genome-wide siRNA screens.
As S2 cells are derived from phagocytic haemocytes, it was
important to establish that entry occurred via the VACV fusion
machinery and not by another mechanism. We demonstrated that
entry was inhibited by a MAb to L1 and was dependent on the
presence of A28, two of the proteins known to be essential for
VACV entry in mammalian cells. VACV entry into mammalian
cells occurs at the plasma membrane and via low pH-dependent
Figure 8. Late gene expression. BS-C-1 (A) and S2 (B) cells were infected at an MOI of 1 PFU per cell with a recombinant VACV with Luc regulated
under the VACV early/late synthetic promoter (WRvFire) or the p11 late promoter (WRvp11Fire) at indicated temperatures. Luc activity was measured
at 16 h after infection. Standard error bars were plotted in both panels but are too close to discern in some places. BS-C-1 (C) and S2 (D) cells were
infected with VACV at an MOI of 20 PFU per cell and pulse-labeled with
35S-labeled amino acids for 30 min intervals at the times indicated and
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. The masses of marker proteins in kDA are indicated on
the left. M denotes mock-infected cells.
doi:10.1371/journal.pone.0017248.g008
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that entry of VACV strain WR into S2 cells was inhibited 99% by
bafilomycin A1, an inhibitor of endosomal acidification, and could
not be enhanced by acidification of the medium, suggesting that
neutral pH fusion with the plasma membrane did not occur to a
significant extent. Indeed, numerous intact virus particles in
vesicles and free cores in the cytoplasm were seen by transmission
electron microscopy, but there were no images of plasma
membrane fusion events, which are readily detected with
mammalian cells. Consistent with these results, we found that S2
cells were less permissive for the IHD-J strain of VACV, which
enters mammalian cells primarily through a neutral pH mecha-
nism [12,45], than the WR strain. Specific entry receptors have
not been defined for VACV although the presence of glycosami-
noglycans and cholesterol on the cell surface are important for
entry of VACV into mammalian cells [46,47]. S2 cells contain cell
surface heparan sulfate proteoglycans [48] but are auxotrophic for
cholesterol. However, S2 cells were grown with cholesterol
containing serum and cholesterol supplementation did not
enhance entry as measured by Luc expression (ZB, unpublished).
Nevertheless, other differences in the distribution of lipids in
mammalian and insect cells could be responsible for the inability
of VACV to fuse with the plasma membrane. The apparent use of
a single entry pathway in S2 cells could simplify the identification
of host factors required for this step by RNAi methods.
The presence of RNA polymerase and transcription factors in
the core of infectious VACV virions allows transcription of early
genes to occur in the cytoplasm soon after entry. Deep RNA
sequencing of HeLa cells infected with VACV defined 118 early
ORFs that were expressed between 30 and 120 min and 93
additional ORFs that were expressed at 4 h, after viral DNA
replication [26]. Using a similar approach, we demonstrated
expression of the same set of early genes but no post-replication
genes even when analyzed 12 h after infection. Moreover, the
VACV early transcripts comprised a similar percentage of the total
polyadenylated RNA in S2 and HeLa cells, indicating efficient
entry and early transcription. The inability to detect late protein
synthesis by pulse-labeling infected cells was consistent with the
absence of late mRNAs.
Transcription of intermediate and late genes occurs in
cytoplasmic viral factories and depends on de novo synthesis of
a large number of early proteins including a multi-subunit DNA-
dependent RNA polymerase and stage-specific transcription
factors in addition to a DNA template. Evidence for additional
host factors has been obtained by in vitro complementation
studies. Therefore, the failure to transcribe intermediate and late
genes could have multiple causes. However, by transfecting
plasmid templates, we bypassed the requirement for replicated
viral genomic DNA and succeeded in demonstrating intermediate
and late gene expression. Thus, the early proteins needed for
intermediate gene expression were synthesized and the data
strongly suggested a block in viral genome replication in S2 cells.
Indeed, we could not detect replication of the viral genome. This
defect could be due to a failure to completely uncoat the packaged
DNA, failure to synthesize adequate amounts of viral replication
proteins, absence of a required mammalian host factor, or
presence of an inhibitory host factor. Attempts to determine the
presence of an uncoating defect as a decrease in viral cores by
confocal microscopy or an increase in naked DNA by real time
PCR were not sufficiently quantitative in S2 cells (ZB, unpub-
lished). However, the capability of VACV-infected S2 cells to
replicate exogenous DNA, which is dependent on all known viral
replication proteins [43], can be tested by transfection of plasmids.
Our inability to detect plasmid synthesis indicated that there was a
primary block in DNA replication, though it did not eliminate an
additional block in genome uncoating. One possibility, consistent
with Western blotting, is that the lower amounts of early proteins
were not sufficient to catalyze DNA replication, an explanation
provided for results obtained in mammalian cells with a
conditional lethal mutant in the VACV capping enzyme [49].
Figure 9. Expression of reporter genes regulated by intermediate and late promoters in transfected plasmids. A) Intermediate
expression. S2 cells were mock infected or infected with VACV strain WR at a MOI of 1 PFU per cell and mock transfected or transfected with a
plasmid containing the Luc ORF regulated by the G8R intermediate promoter. Luc activity was measured at 16 h. B) S2 cells were infected with VACV
strain WR and transfected with a plasmid containing the Luc ORF regulated by the late p11 promoter and cotransfected or not with a second plasmid
containing the three late transcription factor genes (G8R, A1L, A2L) regulated by intermediate promoters. Luc activity was measured at 16 h. Standard
error bars were plotted in both panels but are too close to discern in some places.
doi:10.1371/journal.pone.0017248.g009
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intermediate transcription than for DNA replication and interme-
diate expression could be readily demonstrated by transfection of a
DNA template. An interesting possibility is that cytoplasmic DNA
replication is blocked as a host defense mechanism in S2 cells. The
ability of the DNA binding protein Barrier to Autointegration
Factor (BAF) to inhibit replication of VACV B1 kinase mutants
provides a model for such an activity [50]. The question of
whether a host inhibitory factor is present or a host stimulatory
factor is missing might be answered by carrying out a
comprehensive siRNA screen to test the former and a forward
genetic approach by transfecting a human cDNA library into S2
cells to test the latter, in each case using plasmid replication or
intermediate gene expression as the read out.
Materials and Methods
Cells and viruses
Mammalian BS-C-1 (CCL-26) and HeLa S1 (CCL-2.2) cells
were obtained from the American Type Culture Collection
(Manassas, VA) and maintained in Earle’s minimum essential
medium (EMEM) supplemented with 10% fetal bovine serum,
100 units/ml of penicillin, 100 mg of streptomycin per ml (Quality
Biologicals, Gaithersburg, MD) and 2 mM L-glutamine. S2 cells
were obtained from the Drosophila Genomics Resource Center and
maintained in Schneider Medium (Invitrogen, Carlsbad, CA)
supplemented with 10% heat inactivated fetal bovine serum. The
Western Reserve (WR) strain of VACV (ATTC VR-1354;
GenBank accession number NC_006998), WRvFire [11] and
IHD-JvFire [12] were propagated and the MV purified by sucrose
gradient sedimentation as previously described [12,51]. Recom-
binant WR virus with the firefly luciferase (Luc) open reading
frame attached to the P11 late promoter and inserted between the
F12 and F13 open reading frames was generated as previously
described [12] and named WRvp11Fire. The inserted DNA of the
purified recombinant virus was verified by sequencing. Similarly,
vA28-HAi-Fire was created by inserting the firefly Luc open
reading frame with the synthetic early/late promoter between the
F12 and F13 open reading frames of vA28-HAi [52], a WR strain
virus with an IPTG-regulated HA-tagged A28 protein.
Luc assay
Cells were seeded onto 24-well plates and incubated overnight
at 37uC for mammalian cells and 25uC for S2 cells. Cells were
chilled for 10 min at 4uC and infected with purified MVs at a
multiplicity of infection (MOI) of 1–2 plaque forming units (PFU)
per cell. The virions were allowed to adsorb to cells for 1 h at 4uC
in EMEM-2.5 (EMEM supplemented with 2.5% fetal bovine
serum, 2 mM L-glutamine, 100 units/ml penicillin and 100 mg/
ml streptomycin). Unattached virus was removed by washing and
the infection was allowed to proceed at 31uC unless indicated
otherwise in the Results section. Cells were harvested by
incubation with 200 ml of Cell Culture Lysis Reagent (Promega,
Madison, WI) for 30 min at room temperature on an orbital
shaker. The Luc assay was performed by adding 20 ml of cell lysate
to 100 ml of Luc activity assay substrate (Promega), mixed, and
chemiluminescence measured using a luminometer (Berthold
Sirius, Bad Wilbad, Germany).
Electron microscopy
Purified MVs (150 PFU/cell) were suspended in 0.75 ml
EMEM-2.5 and added to S2 cells that were plated on 6-well
dishes and pre-chilled to 4uC. Plates were wrapped in poly-
vinylidene chloride (Saran Wrap) and placed in a 75006449 C
Figure 10. DNA replication. A) VACV genome replication. BS-C-1
and S2 cells were infected with VACV strain WR (MOI of 5 PFU/cell) in
the presence or absence of AraC. At 0 and 24 h, the amount of VACV
DNA was determined in triplicate by slot blot hybridization using
digoxigenin-dUTP labeled F17R probe. B) Plasmid replication. BS-C-1
and S2 cells were infected with VACV strain WR (MOI of 3 PFU/cell) and
then transfected with a plasmid. At 0, 7 and 24 h, plasmid sequences
were quantified by real-time PCR. Mock infected cells and incubations
without plasmids were used as controls. Standard error bars were
plotted but are too close to discern in some places. C) Western blotting
of VACV DNA replication proteins. BS-C-1 and S2 cells were infected
with VACV (MOI of 20 PFU/cell), incubated after overnight at 31uC in the
presence (+) and absence (-) of AraC analyzed by SDS-polyacrylamide
gel electrophoresis and Western blotting with antibody to the I3, A20,
D5 and E9 proteins. Uninfected cells (U) and cells harvested after
inoculation (I) were used as controls.
doi:10.1371/journal.pone.0017248.g010
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Virus was spinoculated [53] onto cells at 6506g for 1 h at 4uC.
The cells were gently washed and incubated at 31uC for 30, 60 or
120 min, fixed in 2% glutaraldehyde/0.1 M sodium cacodylate
buffer, washed in 0.1 M sodium cacodylate buffer, post-fixed with
reduced osmium tetroxide, and washed in buffer. Cells were
dehydrated successively in 50%, 70%, and 100% ethanol and then
propylene oxide. The samples were embedded in EMbed 812
(Electron Microscopy Sciences, Hatfield, PA) and sections were cut
on a Leica EM UC7 ultramicrotome (Leica Microsystems,
Wetzlar, Germany). Thin sections were stained with 7% uranyl
acetate in 50% ethanol and then 0.01% lead citrate. Sections were
reviewed and photographed on the FEI Tecnai G2 Spirit
transmission electron microscope fitted with a Gatan CCD
camera (FEI Company, Hillsboro, OR). Chemicals were pur-
chased from Electron Microscopy Sciences.
Deep sequencing of RNA from VACV- infected S2 cells
S2 cells were infected with purified VACV at a MOI of 20 PFU
per cell. Preparation and sequencing was carried out as described
[26] with minor modifications. Briefly, polyadenylated RNA was
isolated from VACV-infected S2 cells by two rounds of selection
using the Dynabeads mRNA Direct Kit (Invitrogen). The strand-
specific cDNA library was prepared with the Whole Transcrip-
tome Analysis Kit (Ambion, Austin, TX) using adaptor A and
sequenced with the Applied Biosystems SOLiD 3 system. Multiple
samples were sequenced together using barcodes. The raw reads
were processed with the Applied Biosystems Whole Transcriptome
Analysis (WTA) Pipeline and split-read mapper tool and mapped
to VACV genome (NC_006998) with 2 mismatches allowed.
VACV transcriptome maps were displayed and visualized with
Mochiview [54]. The cDNA sequences were deposited in the
Sequence Read Archive of the National Library of Medicine
under submission access numbers SRA27288 and SRP004868.
DNA replication
BS-C-1 and S2 cells were infected with VACV in 24-well dishes
at 31uC for 24 h. Cells were lysed in 10 X SSC (1.5 M NaCl and
0.15 M sodium citrate pH 7.0) containing 1 M ammonium
acetate by three freeze-thaw cycles. Lysates were cleared by
incubation with Proteinase K (Sigma Aldrich, St. Louis, MO)
followed by sonication. DNA was denatured with 0.4 M NaOH
and 10 mM EDTA for 10 min at 100uC and spotted on Hybond-
N+ (Amersham, Piscataway, NJ) nylon membrane under vacuum.
The blot was washed with 10 X SSC, denatured with 0.5 M
NaOH, 1.5 M NaCl and neutralized with 1.5 M NaCl, 1 M Tris
base before hybridization using QuiK-Hyb solution (Stratagene,
Santa Clara, CA). VACV DNA was detected using digoxigenin-
dUTP labelled F17R gene probe (DIG High Prime DNA labeling
and detection kit, Roche, Indianapolis, IN). Analysis of plasmid
replication was carried out by real-time PCR as previously
described [35,43]. Briefly, 0.1 mg of p716 plasmid [55] and 3.9 mg
of salmon sperm carrier DNA were mixed with 10 mgo f
lipofectamine 2000 (Invitrogen) and uninfected cells were
transfected according to the manufacturer’s instructions. After
24 h, the cells were infected with VACV strain WR at a
multiplicity of 3 PFU per cell. Cells were then washed twice with
Opti-MEM (Invitrogen) and incubated for various times, harvest-
ed and the DNA isolated using the QIAamp DNA Blood Kit
(Qiagen) according to the manufacturer’s instructions. DNA was
digested with restriction enzyme DpnI (New England Biolabs,
Ipswich, MA). Oligonucleotides P1 (59CAACTAAATGTGCA-
AGCAATGTAATTC39) and P2 (59CATCCTGCCCCTTGCT-
GT39) were designed with Primer Express software supplied by
Applied Biosystems. Reactions were carried out using SYBR
Green PCR master mix (Applied Biosystems), 10 mM of each
primer, and 1 ng of DNA in a total volume of 50 ml in an RealPlex
sequence detection system and software (Eppendorf, Westbury,
NY). DNA was amplified with 40 cycles at 95uC for 15 sec and
60uC for 60 sec.
Western blotting
Protein concentrations of cell-lysates were determined using the
micro bicinchonic acid kit (Pierce, Rockford, IL). Equal amounts
of cell-lysates (100 mg) were resolved by sodium dodecyl sulfate
polyacrylamide gel electrophoresis on 4%–12% Novex NuPAGE
acrylamide gels with 2-(N-morpholino)ethansulfonic-sodium dode-
cyl sulfate running buffer and transferred to nitrocellulose
membranes using mini iBlot gel transfer stacks (Invitrogen). After
transfer, the membranes were blocked with 5% nonfat milk in
phosphate buffered saline (PBS) containing 0.05% Tween-20
(PBS-T). Membranes were then incubated with a monoclonal
antibody (MAb) against the I3 protein [56] or polyclonal sera
against VACV DNA polymerase E9 [57], A20 protein [58], or D5
protein [59] overnight at 4uC and washed with PBS-T and PBS.
The membrane was then incubated with donkey anti-mouse
IRDye 680/800 or donkey anti-rabbit IRDye 680/800 for 2 h at
room temperature, washed with PBS-T and PBS and developed
using a LI-COR Odyssey infrared imager (LI-COR Biosciences,
Lincoln, NE).
Supporting Information
Table S1 Normalized read counts of VACV ORFs in
infected Drosophila S2 cells.
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